This is the trouble many times with getting what CYP do.
Mostly misunderstood, and lumped in with biotechs with expensive development pipelines like MSB.
We really are a med-tech in manufacturing chain. A cell expansion platform! for the commercial manufacture of said therapies.
As Fuji shows, and GvHD will show, we are about as lean as they come.
...probably confuse even more lookers
Ann: Cynata Successfully Completes Capital Raising, page-35
-
- There are more pages in this discussion • 99 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.020(9.30%) |
Mkt cap ! $42.45M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 25.0¢ | 21.5¢ | $50.18K | 213.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13511 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 40000 | 1 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |